NDC 70518-0174-01 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0174
- Requested NDC
- 70518-0174-01
- Package NDCs from labels
- 70518-0174-0, 70518-0174-1, 70518-0174-2, 70518-0174-3, 70518-0174-4, 70518-0174-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-06-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP | REMEDYREPACK INC. | 2026-06-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-0174-0 | Lisinopril and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 25 | |
| 70518-0174-1 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 | |
| 70518-0174-2 | Lisinopril and Hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 25 | |
| 70518-0174-3 | Lisinopril and Hydrochlorothiazide | 30 in 1 BLISTER PACK | TABLET | 30 | 25 | |
| 70518-0174-4 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-0174 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 21 | Current NDC, Legacy NDC, 5 package rows | 20250424_408e797a-2cf3-4ee6-9f9b-179a8cf3d799.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | American Health Packaging | ba764ce4-36fe-4aa4-96a4-d0479b875b4f | 2025-01-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Ferrum Silicicum Urtica | FERRUM SILICICUM URTICA | Uriel Pharmacy Inc. | 09829ac4-c074-7315-e063-6394a90adf59 | 2025-01-07 | Warnings | 1K09F3G675 |
| Zestril | LISINOPRIL | Upsher-Smith Laboratories, LLC | 838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Advanced Rx Pharmacy of Tennessee, LLC | ecac0280-6faa-e7f3-e053-2995a90a2bd9 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 197885 E7199S1YWR 0J48LPH2TH |
| Micardis HCT | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | b078dae2-664d-4144-847a-3b9d9b557402 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 4a2c2b8f-1479-4555-9ba8-ca4407003296 | 2024-12-27 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Quality Care Products, LLC | a6241e63-1952-4dfa-ba94-c406059501dd | 2024-12-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Quality Care Products LLC | a2de8e26-ef5a-41c7-888b-990629b11145 | 2024-12-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Quality Care Products LLC | 29e9ac54-f9da-495c-9102-2aac2cc7d88a | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | Quality Care Products LLC | babb75f0-bccc-44e8-955a-6873344ccc21 | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Lake Erie Medical DBA Quality Care Products LLC | 9e6a0c83-1494-44ca-90e0-3f43fa8ec746 | 2024-12-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Aphena Pharma Solutions - Tennessee, LLC | 2902430c-0bfe-483e-e063-6294a90a92d7 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | 197886 E7199S1YWR 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5f2e72cc-073d-4bb5-95fe-53d4060127ec | 2024-12-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals, Inc. | 4f1f76fe-816c-384a-e054-00144ff88e88 | 2024-12-03 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 927315ca-211b-4976-b228-cf544f7e5259 | 2024-11-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | fe49d96e-5874-4b11-9323-b4a92e9c25dc | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 3df6c955-9c38-4e44-a665-dac2a051bd02 | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| candesartan cilexetil and hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | cb328bc1-5738-4620-b2b3-442e98388a86 | 2024-11-11 | 0J48LPH2TH | |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 3f1321b2-cad7-47c7-863f-38aa7a8b3599 | 2024-11-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 93833cf2-631b-4058-809d-16cc11b858c0 | 2024-11-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.